
Lupikem Pharmaceuticals Private Limited
About Lupikem Pharmaceuticals Private Limited
Data last updated:
Lupikem Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 07 November 2023.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U21001WB2023PTC266072.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Arjun Nath and Swapan Nath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24/A Rahim Ostagar Road Po/Ps Lake Garden, Kolkata, West Bengal, India – 700045.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.35 Lakh. For the same year it recorded a net profit of ₹35,140 (net margin 10.5%) and EBITDA of ₹49,500 (EBITDA margin 14.8%).
Company details
Contact details
Lupikem Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal.
- Registered Address24/A Rahim Ostagar Road Po/Ps Lake Garden, Kolkata, West Bengal, India – 700045
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lupikem Pharmaceuticals Private Limited
FY 2025 filings availableLupikem Pharmaceuticals Private Limited reported revenue of ₹3.35 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹49,500 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹35,140 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 14.8% | |
| Net Profit Margin | 10.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lupikem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lupikem Pharmaceuticals Private Limited
Lupikem Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arjun Nath | Director | 07 Nov 2023 | 3 Years 0 Months | Current |
| Swapan Nath | Director | 07 Nov 2023 | 3 Years 0 Months | Current |
| Joyshree Deb Nath | Director | 07 Nov 2023 | 3 Years 0 Months | Current |
Peer comparison
Lupikem Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambiosis Pharmaceuticals Private Limited | ₹3.41 Lakh (FY 2025) | 5.0% | Bhopal, Madhya Pradesh, India | |||
| Sylum Pharmaceuticals Private Limited | ₹3.38 Lakh (FY 2022) | 85.0% | Solan, Himachal Pradesh, India | |||
| Neosum Pharmaceuticals Private Limited | ₹3.37 Lakh (FY 2022) | 25.0% | Delhi, India | |||
| VR Care Pharmaceuticals Private Limited | ₹3.37 Lakh (FY 2024) | -36.0% | Pinjore, Haryana, India | |||
| Goldqura Pharmaceuticals Private Limited | ₹3.35 Lakh (FY 2021) | Bhopal, Madhya Pradesh, India | ||||
| Lupikem Pharmaceuticals Private Limitedthis company | ₹3.35 Lakh (FY 2025) | ₹35,140 | 10.5% | Kolkata, West Bengal, India | ||
| Redgrove Pharmaceuticals India Private Limited | ₹3.34 Lakh (FY 2025) | -99.0% | Mumbai, Maharashtra, India | |||
| Nassid Pharmaceuticals Private Limited | ₹3.34 Lakh (FY 2017) | -2.0% | Lucknow, Uttar Pradesh, India | |||
| Invertis Pharmaceuticals Private Limited | ₹3.33 Lakh (FY 2024) | -16.0% | Ghaziabad, Uttar Pradesh, India | |||
| BLS Pharmaceuticals Private Limited | ₹3.33 Lakh (FY 2020) | -83.0% | Lucknow, Uttar Pradesh, India | |||
| Patcure Pharmaceuticals (Belgaum) Private Limited | ₹3.31 Lakh (FY 2016) | 47.0% | Belgaum, Karnataka, India |
To see the full peer comparison of Lupikem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lupikem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lupikem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lupikem Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lupikem Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Arjun Nath was appointed as Director on 07 Nov 2023.
Frequently asked questions
Lupikem Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in paper and paper products, within the paper industry. It was incorporated on 07 November 2023 (3+ years old) and is registered under CIN U21001WB2023PTC266072.
Lupikem Pharmaceuticals has 3 current directors:
- Arjun Nath - Director
- Swapan Nath - Director
- Joyshree Deb Nath - Director
The latest financial statements of Lupikem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Lupikem Pharmaceuticals is U21001WB2023PTC266072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lupikem Pharmaceuticals was incorporated on 07 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Lupikem Pharmaceuticals by revenue are Ambiosis Pharmaceuticals Private Limited, Sylum Pharmaceuticals Private Limited, Neosum Pharmaceuticals Private Limited, VR Care Pharmaceuticals Private Limited, Goldqura Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arjun Nath was appointed as Director on 07 Nov 2023. Joyshree Deb Nath was appointed as Director on 07 Nov 2023. Swapan Nath was appointed as Director on 07 Nov 2023.
The registered office of Lupikem Pharmaceuticals is at 24A Rahim Ostagar Road PoPs Lake Garden, Kolkata, West Bengal, India – 700045.
Lupikem Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Lupikem Pharmaceuticals can be reached at its registered office: 24A Rahim Ostagar Road PoPs Lake Garden, Kolkata, West Bengal, India – 700045.
Lupikem Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kolkata.

